Three quality and validation colleagues review PPQ results on a tablet beside a process performance screen showing capability indices and three of three PPQ batches.

Process Validation

The process was approved.Was its performance demonstrated?

A signed validation report shows that a protocol was run. The Case File shows what the decision needs to preserve: what the data showed, how unexplained variability was weighed, the risk accepted, and who authorized the process for commercial use before it began.

When the inspector asks what showed this process performs and who decided it could be used, this is the record that answers.

Delivered after payment · 7-day secure download

The problem

A PPQ passed on paper, but one batch or trend does not sit right and you must decide whether the process is qualified.

Who it is for: Heads of Quality who decide whether a process is qualified, and the validation leads who write the conclusion.

What you get

$149 One completed, clearly labeled fictional worked record showing the evidence, judgment, remaining risk and authorization behind the decision. Delivered after payment. It does not assess your own decision.

Your $149 applies toward the $497 Inspection Response Record if you later preserve a real decision.

What to do next

Get the Case File

A page from the finished record

Read one finished decision record before you buy.

Illustrative case. This is an excerpt of the worked record inside the Case File: PPQ protocol PV-2025-0117 for an immediate-release 250 mg tablet, where every result met specification but the hardness capability criterion in PPQ batch 2 was not met. The company, product, people, dates, identifiers, results, cost figures and events are fictional. This is not an FDA observation or a Form 483. In the scenario the firm concluded the process was validated without this record. The excerpt shows the record that should have existed before commercial use.

DecisionDo not conclude the process is qualified; investigate, extend the PPQ, and define monitoring first
Decision ownerDana Whitfield, Vice President, Quality (illustrative)
Authorized9 September 2025, 16:20 EDT, before the PPQ report was approved

What was checked, and against which records

  • Protocol criteria compared. Hardness: every result within specification and a Ppk of at least 1.33 in each PPQ batch.
  • Hardness capability. Ppk 1.52, 1.04 and 1.47 across batches 1 to 3. Batch 2 does not meet the criterion.
  • In-process data. A downward hardness trend in the middle of the batch 2 compression run, then a return to the batch 1 level.
  • Other attributes. Assay, content uniformity and dissolution within specification in all three batches.
  • Deviation log. No deviation opened for the trend; the cause is unconfirmed.

The conclusion, and what was rejected

  • Qualification conclusion held. The criterion was not met in one of three batches, the cause is unconfirmed, and three batches give limited information about between-batch variability. Commercial use is not authorized.
  • Conclude validated because every result met specification. Rejected: the protocol set a capability criterion and no rationale explained why the conclusion still held.
  • Treat batch 2 as isolated and rely on batch 3. Rejected: with no confirmed cause, one recovery batch does not show the drift cannot recur.
  • This is the scenario’s conclusion, not a rule for every PPQ. Batch numbers and criteria are product- and process-specific.

What must happen before it can proceed

  • Technical. Investigate the batch 2 hardness trend and establish a cause, or record the limit of what can be known.
  • Statistical. Execute added PPQ batches under an amended protocol with a justified sampling plan and capability criteria.
  • Quality. Open and close the deviation, approve revised procedures, and hold the PPQ lots pending assessment.
  • Monitoring. Approve a continued process verification plan with defined signals, owners and escalation.

Who authorized the decision

  • Dana Whitfield, Vice President, Quality (illustrative), who held the qualification conclusion and authorized the investigation and added batches.
  • System action. A hold was applied to the PPQ lots, the commercial batch record release and the report approval task.
  • The record shows who held the authority, what they relied on, and when they decided, before commercial use. No one reconstructs it after the lots ship.
A tablet showing the Process Validation Decision Record: evidence, judgment, risk and authorization, with the evidence checklist open.

What the full Case File adds

The whole record, not one page of it.

One completed decision record with the evidence, the judgment, the risk, the authority, and the preventive controls, as a PDF delivered after payment.

Get the Case File — $149 →

The two decisions

Validation needs a qualification decision and a control-strategy decision. A passing PPQ settles neither.

A signed validation report has

  • A protocol
  • Three PPQ batches
  • Results within specification
  • A QA approval

Records an output. Not the basis for it.

An authorization record preserves

  • The result against each criterion
  • How variability was weighed
  • The rationale for the conclusion
  • The monitoring the process needs
  • The accountable owner
  • The conditions before commercial use

The basis, in a form an inspector can read.

Decision 1

Qualification (Stage 2)

  • CriteriaWas every acceptance criterion met, or evaluated and justified?
  • VariabilityWere atypical results and trends investigated?
  • EvidenceDo the data show the process is capable and controlled?
  • RationaleIs the scientific reasoning written down?

OwnerThe scientific and quality conclusion

Decision 2

Control strategy (Stage 3)

  • MonitorWhich parameters and attributes are watched after approval?
  • SignalsWhat statistical signal triggers action?
  • ResidualWhat does the remaining variability mean for the plan?
  • EscalationWho owns the response, and by when?

OwnerThe monitoring program and its escalation

Qualification decision recordedMonitoring plan recordedCommercial use released

The release rule. Release on the recorded decisions, not on a signed report. A successful PPQ is not permanent control. Could the system prove, without reconstruction, why this process was judged capable on that date?

Sources: 21 CFR 211.100 · 21 CFR 211.192 · FDA, Process Validation: General Principles and Practices (January 2011) · ICH Q10

Signals that should slow a validation conclusion

Before concluding a process is qualified, leadership should be able to answer more than “did the batches pass?”

Check your own validation conclusions against these signals.

0 of 4 signals present

See the Case File →

Specification met, capability not shown

Every result is within specification, but the record does not show the protocol’s own capability criteria were evaluated.

SpecificationMet?Not evaluated

Inside the $149 Case File

The process was approved. Now explain the conclusion.

See how one worked example connects the evidence, the reasoning, and accountable approval before commercial use.

The setup · illustrative case

An investigator selects a validation report after commercial lots were distributed, and asks what showed the process performs, how a hardness result that missed the protocol’s own criterion was weighed, and who authorized commercial use. The record held a “validated” conclusion and a QA approval, and nothing behind either. In this scenario that means extra PPQ batches, a review of 14 commercial lots, and a response cost above $1.9 million (an assumption of the case, not a verified figure). Here is what the record would have said.

In the inspector’s chair

The inspector asks

“What did the PPQ data show against your own acceptance criteria?”

1 of 3
A quality scientist in a lab coat and safety glasses reviews process data on a tablet beside stainless steel process equipment.

Get the Case File

Start with the finished validation record.

The Case File is a worked example for leaders and review teams. It does not document your own validation conclusions.

The Record in Practice · Season One. Would your reasoning hold when challenged? Eight weeks of realistic GMP decisions. Make the call, examine the evidence, and strengthen your reasoning.Explore Season One